The balance between antibiotic resistance and fitness/virulence in Pseudomonas aeruginosa: an update on basic knowledge and fundamental research

The balance between antibiotic resistance and fitness/virulence in Pseudomonas aeruginosa: an update on basic knowledge and fundamental research

The interplay between antibiotic resistance and bacterial fitness/virulence has attracted the interest of researchers for decades because of its therapeutic implications, since it is classically assumed that resistance usually entails certain biological costs. Reviews on this topic revise the publis...

Full description

Bibliographic Details
Main Authors:	Elena Jordana-Lluch, Isabel Mª Barceló, María Escobar-Salom, Miguel A. Estévez, Laura Zamorano, Silvia Gómez-Zorrilla, Elena Sendra, Antonio Oliver, Carlos Juan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Microbiology
Subjects:	Pseudomonas aeruginosa antibiotic resistance horizontal β-lactamases AmpC efflux pumps fitness
Online Access:	https://www.frontiersin.org/articles/10.3389/fmicb.2023.1270999/full

Similar Items

Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa
by: Isabel M. Barceló, et al.
Published: (2022-10-01)

Impact of Peptidoglycan Recycling Blockade and Expression of Horizontally Acquired β-Lactamases on Pseudomonas aeruginosa Virulence
by: Isabel M. Barceló, et al.
Published: (2022-02-01)

Filling knowledge gaps related to AmpC-dependent β-lactam resistance in Enterobacter cloacae
by: Isabel M. Barceló, et al.
Published: (2024-01-01)

In vitro activity of human defensins HNP-1 and hBD-3 against multidrug-resistant ESKAPE Gram-negatives of clinical origin and selected peptidoglycan recycling-defective mutants
by: María Escobar-Salom, et al.
Published: (2024-04-01)

Regulation of AmpC-Driven β-Lactam Resistance in <named-content content-type="genus-species">Pseudomonas aeruginosa</named-content>: Different Pathways, Different Signaling
by: Gabriel Torrens, et al.
Published: (2019-12-01)

Effects of Inhaled Corticosteroids on the Innate Immunological Response to <i>Pseudomonas aeruginosa</i> Infection in Patients with COPD
by: Noemi Cerón-Pisa, et al.
Published: (2022-07-01)

In Vitro Activity of Cefotetan against ESBL-Producing Escherichia coli and Klebsiella pneumoniae Bloodstream Isolates from the MERINO Trial
by: Adam G. Stewart, et al.
Published: (2021-09-01)

Phenotypic detection of Metallo- and AmpC β-lactamases producing strains of P. aeruginosa in the state of Himachal Pradesh (India)
by: Naveen Minhas, et al.
Published: (2015-10-01)

Transmission of β-lactamases in the pork food chain: A public health concern
by: Martina Rega, et al.
Published: (2023-12-01)

Clinical outcome of wild-type AmpC-producing Enterobacterales infection in critically ill patients treated with β-lactams: a prospective multicenter study
by: Roman Mounier, et al.
Published: (2022-11-01)

Rapid identification of carbapenemases by CarbAcineto NP test and the rate of beta-lactamases among Acinetobacter baumannii from a teaching hospital
by: Morubagal Raghavendra Rao, et al.
Published: (2022-04-01)

Antibiotic susceptibility pattern in urinary isolates of gram negative bacilli with special reference to AmpC β-lactamase in a tertiary care hospital
by: Patel Mitesh, et al.
Published: (2010-01-01)

Clinical and microbiological observational study on AmpC β-lactamase-producing Enterobacteriaceae in a hospital of Nepal
by: Pankaj Baral, et al.
Published: (2013-04-01)

Multiplex PCR Study of Plasmid-Mediated AmpC Beta-Lactamase Genes in Clinical Isolates of Escherichia coli
by: Maryam Dehghani, et al.
Published: (2016-12-01)

Building an International One Health Strain Level Database to Characterise the Epidemiology of AMR Threats: ESBL—AmpC Producing <i>E. coli</i> as An Example—Challenges and Perspectives
by: Sara Perestrelo, et al.
Published: (2023-03-01)

Prevalence and molecular characteristics of ESBL and AmpC β -lactamase producing Enterobacteriaceae strains isolated from UTIs in Egypt
by: Ebtisam S. Mohamed, et al.
Published: (2020-12-01)

Emergence of serotype K1 Klebsiella pneumoniae ST23 strains co-producing the plasmid-mediated AmpC beta-lactamase DHA-1 and an extended-spectrum beta-lactamase in Korea
by: Hae Suk Cheong, et al.
Published: (2016-11-01)

Prevalence of extended-spectrum beta-lactamases, AmpC beta-lactamase, and metallo-beta-lactamase producing Pseudomonas aeruginosa and Acinetobacter baumannii in an intensive care unit in a tertiary care hospital
by: Varun Goel, et al.
Published: (2013-01-01)

Molecular mechanisms of ceftazidime resistance in Pseudomonas aeruginosa isolates from canine and human infections
by: S.-J. Du, et al.
Published: (2010-04-01)

Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to <i>Enterobacter</i>, <i>Serratia</i>, and <i>Citrobacter</i> Species
by: Caroline Derrick, et al.
Published: (2020-05-01)

Fluoroquinolone Versus Nonfluoroquinolone Treatment of Bloodstream Infections Caused by Chromosomally Mediated AmpC-Producing Enterobacteriaceae
by: Sarah Grace Gunter, et al.
Published: (2020-06-01)

Cefepime vs carbapenems for treating third-generation cephalosporin-resistant AmpC β-lactamase-hyperproducing Enterobacterales bloodstream infections: a multicenter retrospective study
by: Baptiste Hoellinger, et al.
Published: (2023-09-01)

Prevalence and distribution of ampc beta-lactamase producing escherichia coli and klebsiella pneumoniae isolates obtained from urine samples at a tertiary care hospital in the caribbean
by: Camille-Ann Thoms Rodriguez, et al.
Published: (2022-10-01)

Phenotypic detection of extended spectrum ?-lactamase and AmpC ?-lactamase in urinary isolates of Escherichia coli at a tertiary care referral hospital in Northeast India
by: A Bora, et al.
Published: (2013-09-01)

AVALIAÇÃO DO PERFIL DE RESISTÊNCIA DE ENTEROBACTÉRIAS PRODUTORAS DE AMPC NO HOSPITAL DE CLÍNICAS DE PORTO ALEGRE
by: Ana Elize Barin, et al.
Published: (2023-10-01)

A study on detection of extended-spectrum beta-lactamases (ESBLs) and comparison of various phenotypic methods of AmpC detection in Pseudomonas aeruginosa from various clinical isolates in a tertiary care teaching hospital
by: Subbalakshmi Easwaran, et al.
Published: (2016-01-01)

Molecular detection of TEM and AmpC (Dha, mox) broad spectrum β-lactamase in clinical isolates of Escherichia coli
by: Soltan Dallal MM, et al.
Published: (2010-09-01)

Role of AmpR in the High Expression of the Plasmid-Encoded AmpC β-Lactamase CFE-1
by: Ryuichi Nakano, et al.
Published: (2017-08-01)

Plasmid-Encoded AmpC (pAmpC) in Enterobacteriaceae: epidemiology of microorganisms and resistance markers ß-lactamasas de tipo AmpC de codificación plasmídica (pAmpC) en Enterobacteriaceae: epidemiología de los microorganismos y de los marcadores de resistencia
by: Daniela Cejas, et al.
Published: (2012-09-01)

ß-lactamasas AmpC plasmídicas tipo CMY-2 emergentes en Tucumán, Argentina CMY-2-type plasmid-mediated AmpC ß-Lactamases emerging in Tucumán, Argentina
by: María A. Jure, et al.
Published: (2011-03-01)

Molecular Basis of AmpC β-Lactamase Induction by Avibactam in <i>Pseudomonas aeruginosa</i>: PBP Occupancy, Live Cell Binding Dynamics and Impact on Resistant Clinical Isolates Harboring PDC-X Variants
by: Silvia López-Argüello, et al.
Published: (2021-03-01)

Role of Low-Molecular-Mass Penicillin-Binding Proteins, NagZ and AmpR in AmpC β-lactamase Regulation of Yersinia enterocolitica
by: Chang Liu, et al.
Published: (2017-09-01)

Clinical Outcomes of Third-Generation Cephalosporin Definitive Therapy for Bloodstream Infections Due to Enterobacterales with Potential AmpC Induction: A Single-Center Retrospective Study
by: Gilles Vossius, et al.
Published: (2023-09-01)

Prevalence and Antibiogram of Pseudomonas aeruginosa Among Nile Tilapia and Smoked Herring, with an Emphasis on their Antibiotic Resistance Genes (blaTEM, blaSHV, blaOXA-1 and ampC) and Virulence Determinant (oprL and toxA)
by: Dina S. Mohamed, et al.
Published: (2023-08-01)

فراوانی ژن‌های کدکننده‌ی آنزیم‌های بتالاکتامازی AmpC با واسطه‌ی پلاسمید در ایزوله‌های بالینی کلبسیلا پنومونیه
by: Alireza Japoni-Nejad, et al.
Published: (2013-10-01)

Frequency of AmpC Beta-Lactamase Genes in Escherichia Coli Genera of Urinary Tract Infection Isolated from Patients Admitted to Internal Wards of Yazd Hospitals, Iran
by: Ali Mansouri, et al.
Published: (2017-12-01)

Frequency of AmpC β-lactamase Resistance in Escherichia coli Isolates from Urinary Tract Infections in Gorgan, Iran
by: Mahdi Arab Zoozani, et al.
Published: (2017-12-01)

Detection of CMY-type beta-lactamases in Escherichia coli isolates from paediatric patients in a tertiary care hospital in Mexico
by: Jocelin Merida-Vieyra, et al.
Published: (2020-10-01)

Whole genome analyses of CMY-2-producing Escherichia coli isolates from humans, animals and food in Germany
by: Michael Pietsch, et al.
Published: (2018-08-01)

High Prevalence and Mechanism Associated With Extended Spectrum Beta-Lactamase-Positive Phenotype in Laribacter hongkongensis
by: Jade L. L. Teng, et al.
Published: (2021-02-01)